Ascend Advanced Therapies

Ascend Advanced Therapies partners with life science innovators to bring cutting-edge gene therapy products to patients. We offer unparalleled collaboration, guiding your products from the bench through clinical trials and beyond. Our expertise spans gene therapy development and commercialization, leveraging a world-class analytical toolkit within our scalable AAV platform. We prioritize scientific innovation, quality, and responsibility, constantly striving to improve yield and quality in each process. Ascend operates in a dynamic and competitive market, positioning itself as a leader in gene therapy manufacturing. Our unique IP and platform assets give us a competitive edge, while our team of industry veterans—a result of recent acquisitions of Freeline Therapeutics and Beacon Therapeutics teams—brings decades of experience. We offer a collaborative and forward-thinking environment, embracing adaptability and continuous improvement. We are committed to serving patients by serving our partners, fostering a culture of mutual trust and support. Our tech stack includes Amazon web services and CRM software (HubSpot mentioned). We utilize various analytical tools (including, but not limited to, Global Data and Zymewire), and our employees benefit from opportunities for professional development and advancement. With over 120 employees across multiple locations, including Alachua, FL and Rockville, MD, we are rapidly expanding and shaping the future of accessible life-saving therapies. Ascend is a privately held company, recently securing significant funding. Our growth trajectory is robust, driven by a strong pipeline of promising gene therapy projects and a commitment to innovation and excellence.